{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T04:55:26Z","timestamp":1776833726981,"version":"3.51.2"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,10,20]],"date-time":"2019-10-20T00:00:00Z","timestamp":1571529600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,10,20]],"date-time":"2019-10-20T00:00:00Z","timestamp":1571529600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Musculoskelet Disord"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n              <jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The treatment of aneurysmal bone cysts (ABCs) has evolved and less invasive methods have been tried. Denosumab is a monoclonal antibody which inhibits osteoclasts. It has been shown to be effective in giant cell tumour of bone (GCT) of bone and hence promises some effect also in ABC. We report on 6 patients treated with Denosumab and compare our results to the cases already published.<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Data of 6 patients with ABCs and patients whose treatment included Denosumab were retrospectively analyzed. Denosumab was used at a dose of 120\u2009mg on days 1, 8, 15 and 29, and every 4\u2009weeks thereafter. In some of these patients the dose was reduced at the end of the treatment. Clinical and radiological responses were evaluated.<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>In 4 female and 2 male patients with a mean age of 17\u2009years (range: 6\u201330\u2009years) the lesions were located in the sacrum (2), in distal radius, distal femur, talus and pelvis. One of the sacral lesions healed after 12\u2009months and has stayed stable for 3\u2009years since. The second patient received 2\u2009years of therapy with recalcification, but recurred 1 year later and is under renewed therapy. The pelvic lesion improved but recurred. This patient has a 13-years history of intermittent therapy including surgery, two pregnancies and remains in a stable situation. The lesion of the talus did not improve with Denosumab after surgery and was complicated by destruction of the ankle joint with osteoarthritis. Recurrent lesions of the distal femur and the distal radius, previously treated by curettage and bone grafting healed under Denosumab and have remained stable for 2 and 3\u2009years, respectively. One case of severe hypercalcemia was observed in a 7-year old child 6\u2009months after discontinuation of Denosumab.<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Denosumab provides a treatment option for ABCs in anatomically critical locations. Adjuvant application might reduce the rate of local recurrence. In young patients, severe rebound hypercalcemia months after discontinuation of Denosumab may occur.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12891-019-2855-y","type":"journal-article","created":{"date-parts":[[2019,10,20]],"date-time":"2019-10-20T17:47:22Z","timestamp":1571593642000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":60,"title":["Aneurysmal bone cyst: results of an off label treatment with Denosumab"],"prefix":"10.1186","volume":"20","author":[{"given":"Hans Roland","family":"D\u00fcrr","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ferdinand","family":"Grahneis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Baur-Melnyk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Kn\u00f6sel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christof","family":"Birkenmaier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Volkmar","family":"Jansson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Klein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,10,20]]},"reference":[{"key":"2855_CR1","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1001\/archsurg.1942.01210240043003","volume":"44","author":"HL Jaffe","year":"1942","unstructured":"Jaffe HL, Lichtenstein L. Solitary unicameral bone cyst: with emphasis on the roentgen picture, the pathologic appearence and the pathogenesis. Arch Surg. 1942;44:1004\u201325.","journal-title":"Arch Surg"},{"issue":"11","key":"2855_CR2","doi-asserted-by":"publisher","first-page":"2291","DOI":"10.1002\/1097-0142(19880601)61:11<2291::AID-CNCR2820611125>3.0.CO;2-V","volume":"61","author":"V Martinez","year":"1988","unstructured":"Martinez V, Sissons HA. Aneurysmal bone cyst. A review of 123 cases including primary lesions and those secondary to other bone pathology. Cancer. 1988;61(11):2291\u2013304.","journal-title":"Cancer"},{"issue":"12","key":"2855_CR3","doi-asserted-by":"publisher","first-page":"2921","DOI":"10.1002\/1097-0142(19920615)69:12<2921::AID-CNCR2820691210>3.0.CO;2-E","volume":"69","author":"AM Vergel De Dios","year":"1992","unstructured":"Vergel De Dios AM, Bond JR, Shives TC, McLeod RA, Unni KK. Aneurysmal bone cyst. A clinicopathologic study of 238 cases. Cancer. 1992;69(12):2921\u201331.","journal-title":"Cancer"},{"issue":"11","key":"2855_CR4","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1038\/Modpathol.3880224","volume":"13","author":"R Sciot","year":"2000","unstructured":"Sciot R, Dorfman H, Brys P, Dal Cin P, De Wever I, Fletcher CD, Jonson K, Mandahl N, Mertens F, Mitelman F, et al. Cytogenetic-morphologic correlations in aneurysmal bone cyst, giant cell tumor of bone and combined lesions. A report from the CHAMP study group. Mod Pathol. 2000;13(11):1206\u201310.","journal-title":"Mod Pathol"},{"key":"2855_CR5","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1097\/00003086-197311000-00009","volume":"97","author":"JR Clough","year":"1973","unstructured":"Clough JR, Price CH. Aneurysmal bone cyst: pathogenesis and long term results of treatment. Clin Orthop Relat Res. 1973;97:52\u201363.","journal-title":"Clin Orthop Relat Res"},{"issue":"3","key":"2855_CR6","doi-asserted-by":"publisher","first-page":"573","DOI":"10.2214\/ajr.164.3.7863874","volume":"164","author":"MJ Kransdorf","year":"1995","unstructured":"Kransdorf MJ, Sweet DE. Aneurysmal bone cyst: concept, controversy, clinical presentation, and imaging. AJR Am J Roentgenol. 1995;164(3):573\u201380.","journal-title":"AJR Am J Roentgenol"},{"issue":"3","key":"2855_CR7","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1002\/(SICI)1098-2264(199911)26:3<265::AID-GCC12>3.0.CO;2-#","volume":"26","author":"G Panoutsakopoulos","year":"1999","unstructured":"Panoutsakopoulos G, Pandis N, Kyriazoglou I, Gustafson P, Mertens F, Mandahl N. Recurrent t(16;17)(q22;p13) in aneurysmal bone cysts. Genes Chromosomes Cancer. 1999;26(3):265\u20136.","journal-title":"Genes Chromosomes Cancer"},{"issue":"2","key":"2855_CR8","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1002\/gcc.22699","volume":"58","author":"D Baumhoer","year":"2019","unstructured":"Baumhoer D, Amary F, Flanagan AM. An update of molecular pathology of bone tumors. Lessons learned from investigating samples by next generation sequencing. Genes Chromosomes Cancer. 2019;58(2):88\u201399.","journal-title":"Genes Chromosomes Cancer"},{"issue":"25","key":"2855_CR9","doi-asserted-by":"publisher","first-page":"3619","DOI":"10.1038\/onc.2010.116","volume":"29","author":"Y Ye","year":"2010","unstructured":"Ye Y, Pringle LM, Lau AW, Riquelme DN, Wang H, Jiang T, Lev D, Welman A, Blobel GA, Oliveira AM, et al. TRE17\/USP6 oncogene translocated in aneurysmal bone cyst induces matrix metalloproteinase production via activation of NF-kappaB. Oncogene. 2010;29(25):3619\u201329.","journal-title":"Oncogene"},{"issue":"47","key":"2855_CR10","doi-asserted-by":"publisher","first-page":"37111","DOI":"10.1074\/jbc.M110.175133","volume":"285","author":"AW Lau","year":"2010","unstructured":"Lau AW, Pringle LM, Quick L, Riquelme DN, Ye Y, Oliveira AM, Chou MM. TRE17\/ubiquitin-specific protease 6 (USP6) oncogene translocated in aneurysmal bone cyst blocks osteoblastic maturation via an autocrine mechanism involving bone morphogenetic protein dysregulation. J Biol Chem. 2010;285(47):37111\u201320.","journal-title":"J Biol Chem"},{"issue":"4","key":"2855_CR11","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1007\/s12178-016-9371-6","volume":"9","author":"HY Park","year":"2016","unstructured":"Park HY, Yang SK, Sheppard WL, Hegde V, Zoller SD, Nelson SD, Federman N, Bernthal NM. Current management of aneurysmal bone cysts. Curr Rev Musculo Med. 2016;9(4):435\u201344.","journal-title":"Curr Rev Musculo Med"},{"issue":"6","key":"2855_CR12","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1007\/s11999-014-3513-1","volume":"472","author":"KI Reddy","year":"2014","unstructured":"Reddy KI, Sinnaeve F, Gaston CL, Grimer RJ, Carter SR. Aneurysmal bone cysts: do simple treatments work? Clin Orthop Relat Res. 2014;472(6):1901\u201310.","journal-title":"Clin Orthop Relat Res"},{"issue":"8","key":"2855_CR13","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1007\/s00264-016-3364-3","volume":"41","author":"G Rossi","year":"2017","unstructured":"Rossi G, Mavrogenis AF, Facchini G, Bartalena T, Rimondi E, Renzulli M, Andreone A, Durante S, Angelini A, Errani C. How effective is embolization with N-2-butyl-cyanoacrylate for aneurysmal bone cysts? Int Orthop. 2017;41(8):1685\u201392.","journal-title":"Int Orthop"},{"issue":"15","key":"2855_CR14","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1097\/BRS.0000000000002017","volume":"42","author":"S Terzi","year":"2017","unstructured":"Terzi S, Gasbarrini A, Fuiano M, Barbanti Brodano G, Ghermandi R, Bandiera S, Boriani S. Efficacy and safety of selective arterial embolization in the treatment of aneurysmal bone cyst of the Mobile spine: a retrospective observational study. Spine (Phila Pa 1976). 2017;42(15):1130\u20138.","journal-title":"Spine (Phila Pa 1976)"},{"issue":"2","key":"2855_CR15","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.otsr.2015.11.016","volume":"102","author":"F Batisse","year":"2016","unstructured":"Batisse F, Schmitt A, Vendeuvre T, Herbreteau D, Bonnard C. Aneurysmal bone cyst: a 19-case series managed by percutaneous sclerotherapy. Orthop Traumatol Surg Res. 2016;102(2):213\u20136.","journal-title":"Orthop Traumatol Surg Res"},{"issue":"7","key":"2855_CR16","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1359\/JBMR.040305","volume":"19","author":"PJ Bekker","year":"2004","unstructured":"Bekker PJ, Holloway DL, Rasmussen AS, Murphy R, Martin SW, Leese PT, Holmes GB, Dunstan CR, DePaoli AM. A single-dose placebo-controlled study of AMG 162, a fully human monoclonal antibody to RANKL, in postmenopausal women. J Bone Miner Res. 2004;19(7):1059\u201366.","journal-title":"J Bone Miner Res"},{"issue":"4","key":"2855_CR17","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1097\/CCO.0b013e328354c129","volume":"24","author":"DM Thomas","year":"2012","unstructured":"Thomas DM. RANKL, denosumab, and giant cell tumor of bone. Curr Opin Oncol. 2012;24(4):397\u2013403.","journal-title":"Curr Opin Oncol"},{"issue":"5","key":"2855_CR18","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1177\/0300891618784808","volume":"104","author":"E Palmerini","year":"2018","unstructured":"Palmerini E, Ruggieri P, Angelini A, Boriani S, Campanacci D, Milano GM, Cesari M, Paioli A, Longhi A, Abate ME, et al. Denosumab in patients with aneurysmal bone cysts: a case series with preliminary results. Tumori. 2018;104(5):344\u201351.","journal-title":"Tumori"},{"issue":"2","key":"2855_CR19","doi-asserted-by":"publisher","first-page":"e26765","DOI":"10.1002\/pbc.26765","volume":"65","author":"P. J. Leavey","year":"2017","unstructured":"Kurucu N, Akyuz C, Ergen FB, Yalcin B, Kosemehmetoglu K, Ayvaz M, Varan A, Aydin B, Kutluk T. Denosumab treatment in aneurysmal bone cyst: Evaluation of nine cases. Pediatr Blood Cancer. 2018;65(4):e26926. \n                    https:\/\/doi.org\/10.1002\/pbc.26765\n                    \n                  .","journal-title":"Pediatric Blood & Cancer"},{"issue":"6","key":"2855_CR20","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1007\/s00586-013-2715-7","volume":"22","author":"T Lange","year":"2013","unstructured":"Lange T, Stehling C, Frohlich B, Klingenhofer M, Kunkel P, Schneppenheim R, Escherich G, Gosheger G, Hardes J, Jurgens H, et al. Denosumab: a potential new and innovative treatment option for aneurysmal bone cysts. Eur Spine J. 2013;22(6):1417\u201322.","journal-title":"Eur Spine J"},{"key":"2855_CR21","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/1477-7819-12-17","volume":"12","author":"C Pauli","year":"2014","unstructured":"Pauli C, Fuchs B, Pfirrmann C, Bridge JA, Hofer S, Bode B. Response of an aggressive periosteal aneurysmal bone cyst (ABC) of the radius to denosumab therapy. World J Surg Oncol. 2014;12:17.","journal-title":"World J Surg Oncol"},{"issue":"11","key":"2855_CR22","doi-asserted-by":"publisher","first-page":"E654","DOI":"10.1097\/BRS.0000000000001350","volume":"41","author":"A Dubory","year":"2016","unstructured":"Dubory A, Missenard G, Domont J, Court C. Interest of Denosumab for the treatment of Giant-cells tumors and aneurysmal bone cysts of the spine. About Nine Cases. Spine (Phila Pa 1976). 2016;41(11):E654\u201360.","journal-title":"Spine (Phila Pa 1976)"},{"key":"2855_CR23","first-page":"1574343","volume":"2018","author":"PB Fontenot","year":"2018","unstructured":"Fontenot PB, Jesurajan J, Bui M, Reed D, Binitie O. Recurrent aneurysmal bone cyst of the distal fibula treated with Denosumab and curettage. Case Rep Oncol Med. 2018;2018:1574343.","journal-title":"Case Rep Oncol Med"},{"issue":"12","key":"2855_CR24","doi-asserted-by":"publisher","first-page":"E107","DOI":"10.1002\/hed.25438","volume":"40","author":"KW Asi","year":"2018","unstructured":"Asi KW, Abdelmeguid A, Bell D, Hanna EY. Massive aneurysmal bone cyst of the skull base treated with denosumab. Head Neck. 2018;40(12):E107\u2013e113.","journal-title":"Head Neck"},{"issue":"17","key":"2855_CR25","first-page":"3692","volume":"20","author":"R Ghermandi","year":"2016","unstructured":"Ghermandi R, Terzi S, Gasbarrini A, Boriani S. Denosumab: non-surgical treatment option for selective arterial embolization resistant aneurysmal bone cyst of the spine and sacrum. Case report. Eur Rev Med Pharmacol Sci. 2016;20(17):3692\u20135.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"Suppl 3","key":"2855_CR26","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1007\/s00586-018-5528-x","volume":"27","author":"RS Patel","year":"2018","unstructured":"Patel RS, Dhamne CA, Gopinathan A, Kumar N, Kumar N. Denosumab: a potential treatment option for aneurysmal bone cyst of the atlas. Eur Spine J. 2018;27(Suppl 3):494\u2013500.","journal-title":"Eur Spine J"},{"key":"2855_CR27","first-page":"9125493","volume":"2017","author":"D Ntalos","year":"2017","unstructured":"Ntalos D, Priemel M, Schlickewei C, Thiesen DM, Rueger JM, Spiro AS. Therapeutic Management of a Substantial Pelvic Aneurysmatic Bone Cyst Including the off-label use of Denosumab in a 35-year-old female patient. Case Rep Ortho. 2017;2017:9125493.","journal-title":"Case Rep Ortho"},{"issue":"22","key":"2855_CR28","doi-asserted-by":"publisher","first-page":"E1201","DOI":"10.1097\/BRS.0000000000001027","volume":"40","author":"KM Skubitz","year":"2015","unstructured":"Skubitz KM, Peltola JC, Santos ER, Cheng EY. Response of aneurysmal bone cyst to Denosumab. Spine (Phila Pa 1976). 2015;40(22):E1201\u20134.","journal-title":"Spine (Phila Pa 1976)"},{"issue":"2","key":"2855_CR29","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.trsl.2014.03.005","volume":"164","author":"DW Pelle","year":"2014","unstructured":"Pelle DW, Ringler JW, Peacock JD, Kampfschulte K, Scholten DJ 2nd, Davis MM, Mitchell DS, Steensma MR. Targeting receptor-activator of nuclear kappaB ligand in aneurysmal bone cysts: verification of target and therapeutic response. Transl Res. 2014;164(2):139\u201348.","journal-title":"Transl Res"},{"issue":"3","key":"2855_CR30","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/S1470-2045(10)70010-3","volume":"11","author":"D Thomas","year":"2010","unstructured":"Thomas D, Henshaw R, Skubitz K, Chawla S, Staddon A, Blay JY, Roudier M, Smith J, Ye Z, Sohn W, et al. Denosumab in patients with giant-cell tumour of bone: an open-label, phase 2 study. Lancet Oncol. 2010;11(3):275\u201380.","journal-title":"Lancet Oncol"},{"issue":"2","key":"2855_CR31","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1148\/radiol.2322031157","volume":"232","author":"V Topouchian","year":"2004","unstructured":"Topouchian V, Mazda K, Hamze B, Laredo JD, Pennecot GF. Aneurysmal bone cysts in children: complications of fibrosing agent injection. Radiology. 2004;232(2):522\u20136.","journal-title":"Radiology"},{"issue":"6","key":"2855_CR32","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1007\/s11999-009-1144-8","volume":"468","author":"MK Varshney","year":"2010","unstructured":"Varshney MK, Rastogi S, Khan SA, Trikha V. Is sclerotherapy better than intralesional excision for treating aneurysmal bone cysts? Clin Orthop Relat Res. 2010;468(6):1649\u201359.","journal-title":"Clin Orthop Relat Res"},{"issue":"2","key":"2855_CR33","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/BPO.0000000000000413","volume":"36","author":"WE Shiels 2nd","year":"2016","unstructured":"Shiels WE 2nd, Beebe AC, Mayerson JL. Percutaneous doxycycline treatment of Juxtaphyseal aneurysmal bone cysts. J Pediatr Orthop. 2016;36(2):205\u201312.","journal-title":"J Pediatr Orthop"},{"key":"2855_CR34","doi-asserted-by":"publisher","first-page":"100255","DOI":"10.1016\/j.jbo.2019.100255","volume":"18","author":"Ferdinand Grahneis","year":"2019","unstructured":"Grahneis F, Klein A, Baur-Melnyk A, Kn\u00f6sel T, Birkenmaier C, Jansson V, D\u00fcrr HR. Aneurysmal bone cyst: a review of 65 patients. J Bone Oncol. 2019;18:100255. \n                    https:\/\/doi.org\/10.1016\/j.jbo.2019.100255\n                    \n                  .","journal-title":"Journal of Bone Oncology"},{"issue":"2","key":"2855_CR35","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s13277-015-3094-y","volume":"36","author":"PF Wu","year":"2015","unstructured":"Wu PF, Tang JY, Li KH. RANK pathway in giant cell tumor of bone: pathogenesis and therapeutic aspects. Tumour Biol. 2015;36(2):495\u2013501.","journal-title":"Tumour Biol"},{"issue":"4","key":"2855_CR36","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1097\/PAT.0b013e3283463536","volume":"43","author":"KY Won","year":"2011","unstructured":"Won KY, Kalil RK, Kim YW, Park YK. RANK signalling in bone lesions with osteoclast-like giant cells. Pathology. 2011;43(4):318\u201321.","journal-title":"Pathology"},{"issue":"4","key":"2855_CR37","doi-asserted-by":"publisher","first-page":"204","DOI":"10.3928\/01477447-20170627-04","volume":"40","author":"OD Savvidou","year":"2017","unstructured":"Savvidou OD, Bolia IK, Chloros GD, Papanastasiou J, Koutsouradis P, Papagelopoulos PJ. Denosumab: current use in the treatment of primary bone tumors. Orthopedics. 2017;40(4):204\u201310.","journal-title":"Orthopedics"},{"issue":"10","key":"2855_CR38","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1007\/s00402-019-03167-x","volume":"139","author":"Gonzalo Luengo-Alonso","year":"2019","unstructured":"Luengo-Alonso G, Mellado-Romero M, Shemesh S, Ramos-Pascua L, Pretell-Mazzini J. Denosumab treatment for giant-cell tumor of bone: a systematic review of the literature. Arch Orthop Trauma Surg. 2019;139(10):1339\u201349.","journal-title":"Archives of Orthopaedic and Trauma Surgery"},{"issue":"4","key":"2855_CR39","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s11914-017-0380-1","volume":"15","author":"AM Boyce","year":"2017","unstructured":"Boyce AM. Denosumab: an emerging therapy in pediatric bone disorders. Curr Osteoporos Rep. 2017;15(4):283\u201392.","journal-title":"Curr Osteoporos Rep"},{"issue":"3","key":"2855_CR40","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1210\/jc.2013-3081","volume":"99","author":"HD Wang","year":"2014","unstructured":"Wang HD, Boyce AM, Tsai JY, Gafni RI, Farley FA, Kasa-Vubu JZ, Molinolo AA, Collins MT. Effects of denosumab treatment and discontinuation on human growth plates. J Clin Endocrinol Metab. 2014;99(3):891\u20137.","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"2855_CR41","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1002\/jbmr.1603","volume":"27","author":"AM Boyce","year":"2012","unstructured":"Boyce AM, Chong WH, Yao J, Gafni RI, Kelly MH, Chamberlain CE, Bassim C, Cherman N, Ellsworth M, Kasa-Vubu JZ, et al. Denosumab treatment for fibrous dysplasia. J Bone Miner Res. 2012;27(7):1462\u201370.","journal-title":"J Bone Miner Res"},{"issue":"5","key":"2855_CR42","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1111\/jop.12516","volume":"46","author":"M Hernandez","year":"2017","unstructured":"Hernandez M, Phulpin B, Mansuy L, Droz D. Use of new targeted cancer therapies in children: effects on dental development and risk of jaw osteonecrosis: a review. J Oral Pathol Med. 2017;46(5):321\u20136.","journal-title":"J Oral Pathol Med"},{"issue":"3","key":"2855_CR43","first-page":"183","volume":"12","author":"O Semler","year":"2012","unstructured":"Semler O, Netzer C, Hoyer-Kuhn H, Becker J, Eysel P, Schoenau E. First use of the RANKL antibody denosumab in osteogenesis imperfecta type VI. J Musculoskelet Neuronal Interact. 2012;12(3):183\u20138.","journal-title":"J Musculoskelet Neuronal Interact"},{"issue":"6","key":"2855_CR44","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1002\/pbc.25393","volume":"62","author":"N Gossai","year":"2015","unstructured":"Gossai N, Hilgers MV, Polgreen LE, Greengard EG. Critical hypercalcemia following discontinuation of denosumab therapy for metastatic giant cell tumor of bone. Pediatr Blood Cancer. 2015;62(6):1078\u201380.","journal-title":"Pediatr Blood Cancer"},{"key":"2855_CR45","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.bone.2018.12.012","volume":"120","author":"S Roux","year":"2019","unstructured":"Roux S, Massicotte MH, Huot Daneault A, Brazeau-Lamontagne L, Dufresne J. Acute hypercalcemia and excessive bone resorption following anti-RANKL withdrawal: case report and brief literature review. Bone. 2019;120:482\u20136.","journal-title":"Bone"}],"container-title":["BMC Musculoskeletal Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-019-2855-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12891-019-2855-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-019-2855-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,18]],"date-time":"2020-10-18T23:09:39Z","timestamp":1603062579000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmusculoskeletdisord.biomedcentral.com\/articles\/10.1186\/s12891-019-2855-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,20]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["2855"],"URL":"https:\/\/doi.org\/10.1186\/s12891-019-2855-y","relation":{},"ISSN":["1471-2474"],"issn-type":[{"value":"1471-2474","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,20]]},"assertion":[{"value":"13 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the ethics committee of the Medical Faculty, University of Munich. Written consent was obtained from all patients or from the parents of the participants under 16\u2009years of age included in this study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All patients or the parents of the participants under 16\u2009years of age included in this study gave consent for publishing their clinical details along with any radiological images to be published in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"456"}}